Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px

Document › Details

Thermo Fisher Scientific Inc.. (3/16/18). "Press Release: Thermo Fisher Scientific Acquires IntegenX, Provider of Leading Rapid DNA Technology for Human Identification". Carlsbad, CA.

	Organisation	Thermo Fisher Scientific Inc. (NYSE: TMO)
	Group	Thermo Fisher (Group)
	Organisation 2	IntegenX Inc.
	Group	Thermo Fisher (Group)
	Product	genomic technology
	Product 2	forensics
	Index term	IntegenX–Thermo Fisher: investment, 201803 acquisition of IntegenX Inc by Thermo Fisher
	Person	Lee, Rosy (Thermo Fisher 201510 VP + General Manager of Human Identification)

Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has acquired IntegenX Inc., which provides a rapid DNA platform for use in forensics and law enforcement applications. IntegenX products significantly enhance Thermo Fisher's existing HID portfolio and complement its leading human identification chemistries, as well as its qPCR and capillary electrophoresis systems.

IntegenX solutions include the RapidHIT platforms, software analysis tools and related consumables that are highly compatible with Thermo Fisher's short tandem repeat (STR) chemistries for human identification. IntegenX currently provides support to prosecutors and law enforcement in 17 countries where its technology is used in government laboratories to generate forensic DNA profiles from samples in 90 minutes as opposed to the standard processing time of three weeks.

"The development of rapid DNA technology provides law enforcement with the ability to generate results while a suspect is still in custody," said Rosy Lee, vice president of human identification, Thermo Fisher Scientific. "Such a dramatic reduction in time from sample to result has led to an increased demand from law enforcement agencies, and aligns with our strategy to expand our leadership position in the human identification market."

"As the leader in rapid DNA technology, we are thrilled to become part of the company that pioneered the development of the human identification market," stated Robert Schueren, president and chief executive officer of IntegenX. "Combining our market leading technologies with Thermo Fisher's scale and depth of capabilities will benefit both our customers and our employees."

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $20 billion and approximately 70,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.

Media Contact Information:

Ron O'Brien
Phone: 781-622-1242
Email: Ron.obrien@thermofisher.com
Website: http://thermofisher.mediaroom.com/

Record changed: 2018-03-27